NYXOAH SA - ORDINARY SHARES

Nyxoah to Delay Full Year 2020 Earnings Release Until April 9, 2021  

02 Apr 2021 01:02:48 By Nasdaq GlobeNewswire

Nyxoah announces the publication of first positive clinical data in an OSA patient suffering from Complete Concentric Collapse (CCC)

03 Mar 2021 00:58:24 By Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

25 Feb 2021 12:00:28 By Nasdaq GlobeNewswire

Nyxoah to present at the Oppenheimer 31st Annual Healthcare Conference

24 Feb 2021 01:01:35 By Nasdaq GlobeNewswire

Nyxoah receives FDA approval for full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)

09 Feb 2021 01:00:13 By Nasdaq GlobeNewswire

Nyxoah and Vanderbilt University enter exclusive licensing agreement regarding next generation neurostimulation technologies to treat Obstructive Sleep Apnea (OSA)

02 Feb 2021 00:56:05 By Nasdaq GlobeNewswire

Nyxoah announces full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)

26 Jan 2021 01:02:09 By Nasdaq GlobeNewswire

First US patient implanted in the DREAM pivotal IDE study, with the Genio® system for the treatment of Obstructive Sleep Apnea (OSA)

05 Jan 2021 01:39:42 By Nasdaq GlobeNewswire